PUBLISHER: Grand View Research | PRODUCT CODE: 1474849
PUBLISHER: Grand View Research | PRODUCT CODE: 1474849
The Europe medical imaging market size is anticipated to reach USD 17.0 billion by 2030 and is anticipated to grow at a CAGR of 5.1% during the forecast period, according to a new report by Grand View Research, Inc. The growth is attributed to increased awareness of early detection tools, rising aging population, technological advancements, and government investments. The development of advanced imaging modalities, such as MRI, CT scans, ultrasound, and PET scans, has significantly improved diagnostic capabilities, leading to better patient outcomes. According to the National Health Service England, in January 2023, 0.52 million CT scans were reported in England.
Lifestyle-related diseases, such as diabetes, cardiovascular diseases, and obesity, are on the rise due to unhealthy habits, sedentary lifestyles, and stress, leading to a higher demand for healthcare services and early detection tools. The shift towards early detection and diagnosis is expected to boost market growth. In October 2023, Quibim, specializing in imaging biomarkers, partnered with Koninklijke Philips N.V. to provide AI -based imaging solutions for MR prostate exams to enhance early detection of conditions such as cancer and boost first-time diagnosis rates. The partnership leverages Quibim's QP-Prostate software and Philips' high-speed MR imaging to address staff shortages and optimize diagnostic workflows.